Unasyn Dosing and Duration for Epiglottitis
For acute epiglottitis, administer Unasyn (ampicillin-sulbactam) at 1.5-3 g IV every 6 hours in adults (or 300 mg/kg/day divided every 6 hours in children ≥1 year old), continuing for 7-10 days or until clinical resolution with at least 3-4 days of therapy after airway stabilization.
Adult Dosing
The FDA-approved dosing for Unasyn is 1.5 g to 3 g IV every 6 hours 1. This represents:
- 1.5 g = 1 g ampicillin + 0.5 g sulbactam
- 3 g = 2 g ampicillin + 1 g sulbactam
Maximum sulbactam dose: 4 grams per day 1.
Administration Details
- Administer by slow IV injection over 10-15 minutes, OR
- Dilute in 50-100 mL compatible diluent and infuse over 15-30 minutes 1
Pediatric Dosing (≥1 Year Old)
300 mg/kg/day IV divided every 6 hours (this equals 200 mg/kg/day ampicillin + 100 mg/kg/day sulbactam) 1.
- Children ≥40 kg: Use adult dosing
- Maximum sulbactam: 4 grams per day 1
- IM administration safety not established in pediatrics 1
The pediatric dosing from guidelines for various infections consistently recommends 200-300 mg ampicillin/kg/day divided every 4-6 hours 2, 3, which aligns with the FDA label for Unasyn.
Treatment Duration
7-10 days is the recommended duration based on clinical evidence in epiglottitis 4.
- The FDA label states IV therapy should not routinely exceed 14 days 1
- In the landmark pediatric epiglottitis study, patients received parenteral sulbactam/ampicillin (30 mg/kg sulbactam + 200 mg/kg ampicillin per day) with 96% clinical response 4
- Most patients showed rapid improvement within 24-48 hours, but complete courses were administered 4
- Recent adult case reports demonstrate successful treatment with 4 days of IV therapy followed by discharge 5
Clinical Decision Points for Duration:
- Continue IV therapy until fever resolves and airway edema improves (typically 3-4 days)
- Total antibiotic course: 7-10 days
- May transition to oral therapy after clinical stability if oral sultamicillin available, though most complete IV course 4, 5
Renal Dose Adjustment
Adjust frequency in renal impairment 1:
- CrCl ≥30 mL/min: 1.5-3 g every 6-8 hours
- CrCl 15-29 mL/min: 1.5-3 g every 12 hours
- CrCl 5-14 mL/min: 1.5-3 g every 24 hours
Rationale for Unasyn in Epiglottitis
Haemophilus influenzae type b remains a key pathogen, with up to 27% producing beta-lactamase 4. Sulbactam's beta-lactamase inhibition makes ampicillin-sulbactam superior to ampicillin alone.
The combination demonstrated:
- 84% H. influenzae isolation rate from blood cultures in epiglottitis patients 4
- Effective against 27% beta-lactamase-positive strains 4
- 96% clinical cure rate in documented H. influenzae epiglottitis 4
- Safer alternative to chloramphenicol/ampicillin with equivalent efficacy 4
Recent data shows ampicillin monotherapy remains effective in many adult cases 6, but Unasyn provides broader coverage for polymicrobial infections and beta-lactamase producers without added toxicity risk.
Critical Caveats
- Airway management takes absolute priority over antibiotic selection—secure the airway first
- Unasyn has no Pseudomonas coverage; if nosocomial epiglottitis or immunocompromised host, consider broader coverage 7
- Throat and blood cultures frequently negative (especially if antibiotics started pre-admission) 6
- Monitor for complications requiring antibiotic adjustment (abscess formation, treatment failure at 48-72 hours) 6
- Consider dexamethasone adjunctive therapy for airway edema 5